3-Bromo-2-cyanopyridine CAS 55758-02-6

The physicochemical properties of drugs, such as solubility, lipophilicity, stability, etc., have a significant impact on their absorption, distribution, metabolism, and excretion (ADME) processes in the body. 3,4-Pyridinecarboxylic Acid can modify the structure of drug molecules through chemical reactions, improving their physicochemical properties. For example, converting carboxyl groups into ester groups through esterification reactions can increase the lipid solubility of drugs and improve their permeability on cell membranes; By introducing hydrophilic groups such as hydroxyl and amino groups, the water solubility of drugs can be increased, and their dissolution and absorption in the body can be improved.

In the process of drug development, understanding the interaction mechanism between drugs and targets is crucial for discovering new drug targets and optimizing drug molecular structures. 3,4-Pyridinecarboxylic Acid and its derivatives can serve as probe molecules to investigate the binding mode, affinity, and mechanism of action between drugs and targets by interacting with potential drug targets. By utilizing techniques such as nuclear magnetic resonance, mass spectrometry, and X-ray crystallography, the interaction details between probe molecules and targets can be analyzed, providing important information for the discovery and validation of drug targets.

High throughput screening technology is an important means of discovering drug targets and lead compounds. 3,4-Pyridinecarboxylic Acid and its derivatives can be used as members of the screening library to participate in high-throughput screening of drug targets. Through interaction screening with a large number of biomolecules, compounds that can bind to specific targets are discovered, further verifying their biological activity and mechanism of action, and thus identifying potential drug targets. In high-throughput screening for a certain disease-related protein, a library of compounds containing 3,4-Pyridinedioxycarboxylic Acid derivatives is screened for interaction with the protein. Using techniques such as fluorescence polarization and surface plasmon resonance to detect the binding between compounds and proteins, and screening compounds with binding activity.

3,4-Pyridinecarboxylic Acid and its derivatives exhibit certain fluorescence properties. Its fluorescence emission may be related to the π - conjugated system and electronic transitions in the molecular structure. By introducing different substituents or combining with other fluorescent groups, its fluorescence properties, such as emission wavelength and fluorescence intensity, can be regulated. Researchers have synthesized a series of materials with different fluorescent colors by reacting 3,4-Pyridinedioic Acid with some organic molecules with fluorescent properties.

The pyridine ring and carboxyl group in 3,4-PyridinedioxyAcid can participate in electrochemical reactions and exhibit certain electrochemical activity. For example, it can serve as a modifier for electrode materials, improving the surface properties and electrochemical performance of electrodes. By modifying the surface of the electrode with 3,4-Pyridinedioic Acid, the specific surface area of the electrode can be increased, and the conductivity and electrocatalytic activity of the electrode can be improved. In the field of batteries, 3,4-Pyridinedioic Acid and its derivatives can be used to prepare battery electrode materials or electrolyte additives to improve battery performance. For example, in lithium-ion batteries, using it as an additive for electrode materials can improve the charging and discharging performance and cycling stability of the electrode.

3-Bromo-2-cyanopyridine, an important heterocyclic organic synthetic building block, was first reported in 1985, with its initial discovery rooted in the exploration of efficient synthesis methods for pyridine derivatives. Unlike compounds developed for specific medical or biological purposes, its discovery was driven by the growing demand for versatile intermediates in pharmaceutical chemistry, organic synthesis, and later material chemistry.

The first synthesis of 3-Bromo-2-cyanopyridine was published in the journal Chemical and Pharmaceutical Bulletin in 1985 (Vol. 33(2), 565-571). The research team adopted 3-bromopyridine as the raw material, which underwent pyridine N-oxidation first and then reacted with trimethylsilyl cyanide to introduce a cyano group at the 2-position of the pyridine ring, forming the target compound. This synthetic route became the most widely used method after its discovery, laying the foundation for the subsequent application and research of 3-Bromo-2-cyanopyridine.

After its initial discovery, researchers focused on optimizing its synthetic process to address existing drawbacks, such as the high exothermic risk of the pyridine N-oxidation step, the high cost of trimethylsilyl cyanide, and the formation of by-products. Multiple patents and research papers (including U.S. patents and international applications) have reported process improvements since then, though the core synthetic pathway remained unchanged. Today, its discovery and subsequent optimization continue to support its widespread use as a key intermediate in various fields, fulfilling the initial demand for efficient and versatile pyridine derivatives.